Why are we even talking to a company with such little innovation?

[Anonymous]

It seems many Bio-Pharma/Device companies are focusing on innovation and selling off their Pharma units to companies like Actavis and moving toward Biotechnology and device. I am perplexed as to why Allergan is not looking into the future and considering buying companies focusing more on Biotechnology. Pharma's future is not bright. Actavis will destroy Allergan by mixing it in with it's me too pharma products. Could their be a better route? I feel we are damned any way you look at it.

 

[Anonymous]

It seems many Bio-Pharma/Device companies are focusing on innovation and selling off their Pharma units to companies like Actavis and moving toward Biotechnology and device. I am perplexed as to why Allergan is not looking into the future and considering buying companies focusing more on Biotechnology. Pharma's future is not bright. Actavis will destroy Allergan by mixing it in with it's me too pharma products. Could their be a better route? I feel we are damned any way you look at it.

Unfortunately, you are correct. Unless we are our own separate entity under Actavis, the way Genzyme is with Sanofi. Meaning no "mixing" us with them. We are still basically Allergan operating the same way we do now with the only synergies coming in HR, Accounting, Finance, .... etc type roles. If Allergan becomes the biotech, Med-device, specialty pharma company under the Actavis umbrella it might be ok but if we get fully integrated it will destroy our commercial and R&D value.

 

[Anonymous]

Unfortunately, you are correct. Unless we are our own separate entity under Actavis, the way Genzyme is with Sanofi. Meaning no "mixing" us with them. We are still basically Allergan operating the same way we do now with the only synergies coming in HR, Accounting, Finance, .... etc type roles. If Allergan becomes the biotech, Med-device, specialty pharma company under the Actavis umbrella it might be ok but if we get fully integrated it will destroy our commercial and R&D value.

Our R&D has brought very little ROI. Soon we will be Actavis and soon many of us will not have jobs. We needed to stand alone and unfortunately that isn't going to happen.

 

[Anonymous]

You know what, anything but vrx or Ackman. I am sick and tired of those two

 

[Anonymous]

Our R&D has brought very little ROI. Soon we will be Actavis and soon many of us will not have jobs. We needed to stand alone and unfortunately that isn't going to happen.

Adios Allergan.